NCT07646353

First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2026-06-12Est. Completion: 2028-04-19

Enrollment target: 40 participants

Contact

Malaria, Falciparum

This is a single-centre, participant- and investigator-blind, randomised, placebo controlled, single ascending dose stud…

Nottingham, United KingdomEst. completion Dec 2, 2027

Malaria

This is a First-in-Human (FiH), randomized, two-part, dose-escalation trial of MAM01 monoclonal antibody (mAb) targeting…

Baltimore, United StatesCompleted Dec 13, 2024

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.